Although calcitonin screening is not required nor recommended in all individuals before starting a GLP-1 agonist outside of a clinical trial, in the case of this patient, it aided in early identification of MTC and familial MEN 2 [14]. The gene discussed is GCG; the disease is medullary thyroid gland carcinoma.